Cargando…
Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells
Several studies have demonstrated the role of platelets in promoting cancer metastasis. Platelets bind to and protect circulating tumor cells (CTCs) from hemodynamic forces and immune cells, and also promote tumor cell arrest in the vasculature and extravasation. Thus, platelets represent a promisin...
Autores principales: | Ortiz-Otero, Nerymar, Marshall, Jocelyn R., Lash, Bradley W., King, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419179/ https://www.ncbi.nlm.nih.gov/pubmed/36132797 http://dx.doi.org/10.1039/d0na00271b |
Ejemplares similares
-
Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020) -
TRAIL-coated leukocytes to kill circulating tumor cells in the flowing blood from prostate cancer patients
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2021) -
Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
por: Grayson, Korie A., et al.
Publicado: (2021) -
Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression
por: Ortiz-Otero, Nerymar, et al.
Publicado: (2020) -
Oxaliplatin resistance in colorectal cancer enhances TRAIL sensitivity via death receptor 4 upregulation and lipid raft localization
por: Greenlee, Joshua D, et al.
Publicado: (2021)